In a New York Times report, Dr. Jerome Kassirer, a former editor of The New England Journal of Medicine, explains: “When researchers are beholden to [pharmaceutical] companies for much of their income, there is an incredible tendency to get results that are favorable to the company. ”
Ajalehes „The New York Times ” selgitas dr Jerome Kassirer,„ The New England Journal of Medicine ” endine toimetaja: „Kui teadlaste sissetulek sõltub suuresti [farmaatsia] ettevõtetest, sunnib neid uskumatult tugev kihk esitama tulemusi, mis ettevõttele sobivad. ”